Adjuvant discovery and development are critical to NIAID efforts to develop new and improved vaccines against infectious diseases.
In November 2010, NIAID convened a blue ribbon panel to discuss the Institute’s research agenda for the discovery, development, and clinical evaluation of vaccine adjuvants. With the panel’s input, the Institute developed the NIAID Strategic Plan for Research on Vaccine Adjuvants. Today, NIAID-funded scientists continue to make progress in three areas of research: basic immunology and early-stage adjuvant discovery, later-stage adjuvant development and preclinical testing, and evaluation in clinical studies.
Short-term goals of the plan include the following:
Long-term goals include the following:
Last Updated May 13, 2014
Last Reviewed May 13, 2014